Current treatment status-Did not start treatment yet - Page 2 of 36 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Comparing chemotherapy-free treatments for patients with treatment naïve chronic lymphocytic leukemia

Comparing chemotherapy-free treatments for patients with treatment naïve chronic lymphocytic leukemia

Posted by on Oct 17, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate three different chemotherapy-free treatment regimens for patients with chronic lymphocytic leukemia.  This study concluded that acalabrutinib (Calquence) plus obinutuzumab (Gazyva) improved survival without cancer worsening for these patients.   Some background Chemotherapy-free...

Read More

Evaluating the impact of surgical removal of tumors in non-Hodgkin lymphoma.

Evaluating the impact of surgical removal of tumors in non-Hodgkin lymphoma.

Posted by on Sep 29, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness of complete surgical removal of aggressive non-Hodgkin lymphoma (NHL). The authors found that in young patients with diffuse large B-cell lymphoma (DLBCL) may benefit from complete surgical removal of the tumor before immunochemotherapy (ICT).  Some background Lymphoma is a cancer that...

Read More

Should azacitidine and venetoclax be used to treat older patients with acute myeloid leukemia?

Should azacitidine and venetoclax be used to treat older patients with acute myeloid leukemia?

Posted by on Sep 27, 2020 in Leukemia | 0 comments

In a nutshell This trial was carried out to assess the effectiveness of azacitidine (Vidaza) in combination with venetoclax (Venclexta) for the treatment of untreated acute myeloid leukemia (AML) in older adults. The authors concluded that this combination prolonged survival and induced more remissions in these patients. Some...

Read More

Are radiotherapy and surgery equally good at treating localized prostate cancer?

Are radiotherapy and surgery equally good at treating localized prostate cancer?

Posted by on Sep 26, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared surgery and radiotherapy for treating localized prostate cancer. They found no significant difference in survival between the two treatments. Some background Localized prostate cancer (cancer which has not spread beyond the prostate gland) can be treated with either surgery, radiotherapy, or monitoring without...

Read More

An examination of pertuzumab and trastuzumab as breast cancer treatment before surgery in a real-life setting

An examination of pertuzumab and trastuzumab as breast cancer treatment before surgery in a real-life setting

Posted by on Sep 26, 2020 in Breast cancer | 0 comments

In a nutshell This study examined the effectiveness and safety of the drug combination pertuzumab (Perjeta) and trastuzumab (Herceptin) as a treatment for breast cancer (BC) with positive HER2 (human epidermal growth factor receptor 2) before surgery to remove the tumor in a real-world setting. The data showed that this...

Read More

Evaluating sorafenib maintenance therapy in patients with acute myeloid leukemia with FLT3-ITD mutation undergoing allogeneic HSCT

Evaluating sorafenib maintenance therapy in patients with acute myeloid leukemia with FLT3-ITD mutation undergoing allogeneic HSCT

Posted by on Sep 25, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated outcomes of sorafenib (Nexavar) maintenance therapy after allogeneic hematopoietic stem cell transplantation (alloHSCT) in patients with acute myeloid leukemia (AML) carrying FLT3-ITD mutation (abnormal gene). The authors found that this therapy was effective and tolerable after aHSCT in such patients. Some...

Read More

Evaluating lenalidomide-rituximab treatment for follicular lymphoma

Evaluating lenalidomide-rituximab treatment for follicular lymphoma

Posted by on Aug 23, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effectiveness of rituxumab (Rituxan) with lenalidomide (Revlimid) for untreated follicular lymphoma (FL). It found that this treatment was more effective than rituxumab with chemotherapy. They also found that blood tests of trace FL can predict outcomes. Some background Follicular lymphoma (FL) is a slow-growing...

Read More

Looking for patients with untreated extensive-stage small cell lung cancer to trial a immunotherapy combination

Looking for patients with untreated extensive-stage small cell lung cancer to trial a immunotherapy combination

Posted by on Aug 15, 2020 in Lung cancer | 0 comments

In a nutshell This trial is examining the effectiveness of atezolizumab (Tecentriq) plus carboplatin (Paraplatin) and etoposide (Etopophos) with or without tiragolumab in patients with untreated extensive-stage small-cell lung cancer (ES-SCLC). The main outcomes that will be measured are progression-free survival (PFS) and overall survival...

Read More

Treating BRAFV600 mutation-positive advanced melanoma with atezolizumab, vemurafenib, and cobimetinib

Treating BRAFV600 mutation-positive advanced melanoma with atezolizumab, vemurafenib, and cobimetinib

Posted by on Jul 12, 2020 in Melanoma | 0 comments

In a nutshell The study evaluated whether the combination of atezolizumab (Tecentriq), vemurafenib (Zelboraf), and cobimetinib (Cotellic) or AVC can effectively treat patients with BRAFV600 mutation-positive advanced melanoma (AM). The authors found that this combination was safe and effective as an initial treatment in such...

Read More